Non-Melanoma Skin Cancer of the Head and Neck

ISBN-13: 9788132224969 / Angielski / Twarda / 2015 / 201 str.

Faruque Riffat; Carsten E. Palme; Michael Veness

Opis

Non-melanoma Skin Cancer of the Head and Neck

Spis treści

Epidemiology and aetiology of non-melanoma skin cancer.- Pathology reporting of non-melanoma skin cancer at the ICPMR.-Evaluation, staging and prognostication.- Non-melanoma skin cancer: Primary non-surgical therapies   and prevention strategies.- Mohs surgery and facial flaps.- Merkel cell carcinoma, adnexal carcinoma  and basal cell carcinoma.- The role of sentinel lymph node biopsy in non-melanoma skin cancer of the head and neck.- Metastatic cutaneous squamous cell carcinoma  of the head and neck.- Managing perineural and skull base involvement.- Squamous cell carcinoma extending to the temporal bone.- Reconstructive options for the face.- Management of critically ill head and neck surgical patients.- Future directions in the management of  non-melanoma skin cancer 

O autorze

FARUQUE RIFFAT

Consultant Otolaryngologist, Head and Neck SurgeonClinical Senior Lecturer, University of Sydney, Westmead Hospital, Australia

CARSTEN E. PALME
Clinical Associate Professor, Otolaryngology Head and Neck Surgery
Royal Prince Alfred Hospital and Westmead Hospital, Sydney, Australia

MICHAEL VENESS
Clinical Professor, University of Sydney
Westmead Hospital, Sydney, Australia

Blurb

Non-melanoma skin cancer is a global public health issue. With an ever-increasing, and ageing, world population coupled with increasing numbers of immunosuppressed individuals the number of patients continues to rise. The head and neck is overwhelmingly the most frequent location for the development of a non-melanoma skin cancer and as such challenges the clinician with its complex anatomy. The importance of maintaining the aesthetics of the face and the function of the anatomy cannot be overstated, yet ultimately it is always the aim of curing a patient with the minimum of morbidity that clinicians strive for. However, the spectrum of presentations and subsequent management varies widely, ranging from patients with the ubiquitous low-risk mid-face basal cell carcinoma to those diagnosed with relatively uncommon but potentially life-threatening high-risk squamous cell carcinomas (e.g. involving metastatic lymph nodes or with perineural invasion present) and Merkel cell carcinomas.